Abstract: Devices and methods are provided for an implantable medical device which is degradable over a clinically relevant period of time. The medical devices may have the form of implants, graft implants, vascular implants, non vascular implants, wound closure implants, sutures, drug delivery implants, biologic delivery implants, urinary tract implants, inter-uterine implants, organ implants, bone implants including bone plates, bone screws, dental implants, spinal disks, or the like. In preferred embodiments, the implantable medical device comprises an implantable luminal prosthesis, such as vascular and non-vascular stents and stents grafts.

Abstract: Biodegradable endoprostheses are formed from amorphous polymers having desirable biodegradation characteristics. The strength of such amorphous polymers is enhanced by annealing to increase crystallinity without substantially increasing the biodegradation time.

Abstract: Methods and apparatuses are provided for providing service recovery at a user equipment (UE) of a mobile communication network. The UE establishes a call in a first public land mobile network (PLMN). A handover zone of the first PLMN and a second PLMN is entered. The second PLMN is in a forbidden PLMN list of the UE. The UE receives a dedicated message with an indication of the second PLMN. The second PLMN is removed from the forbidden PLMN list. The UE performs registration with the second PLMN so that services of the second PLMN are available to the UE.

Abstract: Stents are provided with scaffold structures which have low exposures when implanted in arteries and other blood vessels and lumens. The cross-sectional dimensions, materials, and patterns are controlled to provide sufficient strength and coverage while maintaining the low exposure.

Abstract: A biodegradable stent prosthesis formed from a degradable material, having a plurality of luminal, abluminal, and side surface regions, wherein a surface portion extending between the abluminal and luminal surface region of at least some structural elements is convex.

Abstract: A biodegradable stent prosthesis formed from a degradable polymeric material, having a plurality of luminal, abluminal, and side surfaces, where at least some of the abluminal surfaces are concave and optionally the side surfaces are convex.

Abstract: A biodegradable stent prosthesis formed from a degradable material, having a plurality of luminal, abluminal, and side surface regions, wherein a surface portion extending between the abluminal and luminal surface region of at least some structural elements is convex or bulbous and optionally, where at least some of the abluminal surface regions may be concave.

Abstract: A biodegradable stent prosthesis formed from a degradable polymeric material, having a plurality of luminal, abluminal, and side surfaces, where at least some of the abluminal surfaces are concave and optionally the side surfaces are convex.

Abstract: Disclosed is a system and method for processing a transaction. The method comprises receiving an input data from a user. The input data is associated with the transaction. The method further comprises creating a decision tree or a decision table based upon the input data and pre-defined rules. The decision tree comprises a parent node and a child node. The parent node and the child node comprise a first question and a second question respectively presented to the user. The decision table comprises a plurality of criteria/conditions being presented to the user. For each criteria/condition, a conditional response is received from the user. The method further comprises processing the transaction by identifying a solution, stored in a database, based on the decision tree or the decision table.

Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.

Abstract: Methods and apparatuses are provided for preserving a signaling connection using a UE in a wireless network. An RAU request message is sent from the UE, to at least one network node in the wireless network, when a suspension condition is detected at the UE while the UE is in a connected state. The UE receives a RAU response message from the at least one network node. Activation of a timer is restricted at the UE to preserve the signaling connection in response to receipt of the RAU response message, when at least one radio bearer associated with the UE is detected.

Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.

Abstract: An apparatus and method of a User Equipment (UE) for preserving an active state of an Idle Mode Signaling Reduction (ISR) function in a wireless communication network are provided. The method includes sending, by the UE, during an Inter-Radio Access technology (RAT)/System change, an area update request message to a node in the wireless communication network; receiving, by the UE, an area update accept message from the node; and setting, by the UE, a Temporary Identity Used in Next Update (TIN) parameter to a RAT-related Temporary Mobile Subscriber Identity (TMSI) to preserve the ISR function, in response to receiving the area update accept message, when a status of a periodic area update timer is deactivated.

Abstract: A system and method for providing multi-processor data plane architecture have been provided. The method comprises selecting several processing units for performing an egress data process and an ingress data process. A number of processing units are selected for performing an egress data process based on a type of switch and data rate. Several processing pipes are provided for each processing unit. Each processing pipe is divided into several processing stages based on a number of lookup tables used in the egress data process and the ingress data process to absorb a response time of a memory device. The data is stored in several databases in each processing unit, and the databases are copied into several banks to increase an access time with a storage device, such as DDR-SDRAM. Several headers are resynchronized using a fixed delay time through an ACL unit.

Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.

Abstract: Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients.

Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.

Abstract: Biodegradable endoprostheses are formed from amorphous polymers having desirable biodegradation characteristics. The strength of such amorphous polymers is enhanced by annealing to increase crystallinity without substantially increasing the biodegradation time.

Abstract: Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients.

Abstract: The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.